Cochrane · systematic review · CD009899

Exercise and mobilisation interventions for carpal tunnel syndrome

Page, MJ, O'Connor, D, Pitt, V, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

NeuromuscularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 8 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Neurodynamic mobilisation compared with no treatment for carpal tunnel syndrome

Population: People with carpal tunnel syndrome on a waiting list for carpal tunnel release
8 questions
OutcomeEffectEvidenceStatus / GRADE
Short‐term overall improvement (three months or less)
Neurodynamic mobilisation vs no treatment
RR 15 [1.02, 220.92]1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Adverse effects
Neurodynamic mobilisation vs no treatment
no estimate extracted1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Short‐term improvement in CTS symptoms (VAS pain) (three months or less) Scale from: 0 to 5
Neurodynamic mobilisation vs no treatment
no estimate extracted1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Short‐term improvement in functional ability or health‐related quality of life (hand function) (three months or less)
Neurodynamic mobilisation vs no treatment
RR 9 [0.59, 137.65]1 study · 12 participantsVery low
Downgraded: risk of bias, imprecision
Short‐term improvement in neurophysiologic parameters (three months or less)
Neurodynamic mobilisation vs no treatment
no estimate extracted1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Long‐term improvement in CTS symptoms (more than three months)
Neurodynamic mobilisation vs no treatment
no estimate extracted1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Long‐term improvement in functional ability or health‐related quality of life (more than three months)
Neurodynamic mobilisation vs no treatment
no estimate extracted1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision
Need for surgery
Neurodynamic mobilisation vs no treatment
RR 0.33 [0.1, 1.12]1 study · 14 participantsVery low
Downgraded: risk of bias, imprecision